Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Bylund

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Personalized Medicine|May 24, 2018
Today's research, tomorrow's health: focus on pharmacogenomicsDavid B Bylund, Megan E Kozisek, Megan D Montgomery, et al.
Biochemical Pharmacology|November 26, 2013
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st centuryTerry Kenakin, David B Bylund, Myron L Toews, et al.
Brain Research|July 21, 2006
Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout miceJeff D Sanders, Patricia Szot, David Weinshenker, et al.
Molecular Interventions|January 6, 2006
NIGMS-sponsored integrative and organ systems pharmacology: synopsis of the 2005 experience/anticipation of the 2006 short coursesDavid B Bylund, Laurence L Brunton, Peter J R Cobbett, et al.
Psychopharmacology|April 24, 2009
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile ratsAbbey L Reed, Jeffrey C Anderson, David B Bylund, et al.
Behavioural Brain Research|February 22, 2011
Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilienceManish Taneja, Samina Salim, Kaustuv Saha, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolinesGary L Grunewald, F Anthony Romero, Mitchell R Seim, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Personalized Medicine|May 24, 2018
Today's research, tomorrow's health: focus on pharmacogenomicsDavid B Bylund, Megan E Kozisek, Megan D Montgomery, et al.
Biochemical Pharmacology|November 26, 2013
Replicated, replicable and relevant-target engagement and pharmacological experimentation in the 21st centuryTerry Kenakin, David B Bylund, Myron L Toews, et al.
Brain Research|July 21, 2006
Analysis of brain adrenergic receptors in dopamine-beta-hydroxylase knockout miceJeff D Sanders, Patricia Szot, David Weinshenker, et al.
Molecular Interventions|January 6, 2006
NIGMS-sponsored integrative and organ systems pharmacology: synopsis of the 2005 experience/anticipation of the 2006 short coursesDavid B Bylund, Laurence L Brunton, Peter J R Cobbett, et al.
Psychopharmacology|April 24, 2009
Treatment with escitalopram but not desipramine decreases escape latency times in a learned helplessness model using juvenile ratsAbbey L Reed, Jeffrey C Anderson, David B Bylund, et al.
Behavioural Brain Research|February 22, 2011
Differential effects of inescapable stress on locus coeruleus GRK3, alpha2-adrenoceptor and CRF1 receptor levels in learned helpless and non-helpless rats: a potential link to stress resilienceManish Taneja, Samina Salim, Kaustuv Saha, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Exploring the active site of phenylethanolamine N-methyltransferase with 3-hydroxyethyl- and 3-hydroxypropyl-7-substituted-1,2,3,4-tetrahydroisoquinolinesGary L Grunewald, F Anthony Romero, Mitchell R Seim, et al.
Pageof 3